JPS4969648A - - Google Patents

Info

Publication number
JPS4969648A
JPS4969648A JP48105836A JP10583673A JPS4969648A JP S4969648 A JPS4969648 A JP S4969648A JP 48105836 A JP48105836 A JP 48105836A JP 10583673 A JP10583673 A JP 10583673A JP S4969648 A JPS4969648 A JP S4969648A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48105836A
Other languages
Japanese (ja)
Other versions
JPS5327263B2 (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4969648A publication Critical patent/JPS4969648A/ja
Publication of JPS5327263B2 publication Critical patent/JPS5327263B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
JP10583673A 1972-09-18 1973-09-18 Expired JPS5327263B2 (enExample)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4315072 1972-09-18
GB998773*[A GB1405444A (en) 1972-09-18 1973-03-01 2-aminoindane derivatives
GB998873 1973-03-01
GB1030373 1973-03-02

Publications (2)

Publication Number Publication Date
JPS4969648A true JPS4969648A (enExample) 1974-07-05
JPS5327263B2 JPS5327263B2 (enExample) 1978-08-07

Family

ID=27447738

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10583673A Expired JPS5327263B2 (enExample) 1972-09-18 1973-09-18

Country Status (13)

Country Link
JP (1) JPS5327263B2 (enExample)
AR (4) AR206505A1 (enExample)
CA (1) CA992547A (enExample)
CH (1) CH585690A5 (enExample)
DD (2) DD109802A5 (enExample)
ES (3) ES418827A1 (enExample)
FR (1) FR2199988B1 (enExample)
GB (1) GB1405444A (enExample)
HU (1) HU168018B (enExample)
IL (1) IL43218A (enExample)
LU (1) LU68426A1 (enExample)
MX (1) MX3233E (enExample)
NL (1) NL152246B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975461A (en) * 1986-06-19 1990-12-04 E. R. Squibb & Sons, Inc. P-aminophenols, derivatives thereof and method of use
JPH0293610U (enExample) * 1989-01-09 1990-07-25
EP1658847A3 (en) * 1999-06-10 2006-07-26 Bridge Pharma, Inc. Indane derivatives as dermal anesthetic agents
NZ515143A (en) * 1999-06-10 2004-05-28 Bridge Pharma Inc Aminoindane piperidine compounds as dermal anesthetic agents
WO2001021206A1 (en) 1999-09-17 2001-03-29 Suntory Limited PREVENTIVES OR REMEDIES FOR MYOCARDITIS, DILATED CARDIOMYOPATHY AND CARDIAC INSUFFICIENCY CONTAINING NF-λB INHIBITORS AS THE ACTIVE INGREDIENT
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US7592458B2 (en) 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain

Also Published As

Publication number Publication date
ES418827A1 (es) 1977-02-01
AU6028373A (en) 1975-03-13
AR206505A1 (es) 1976-07-30
LU68426A1 (enExample) 1973-11-26
AR203500A1 (es) 1975-09-15
MX3233E (es) 1980-08-05
NL7312776A (enExample) 1974-03-20
CH585690A5 (enExample) 1977-03-15
JPS5327263B2 (enExample) 1978-08-07
GB1405444A (en) 1975-09-10
DD108277A5 (enExample) 1974-09-12
ES440030A1 (es) 1977-02-16
FR2199988B1 (enExample) 1977-11-25
IL43218A (en) 1977-05-31
HU168018B (enExample) 1976-02-28
DD109802A5 (enExample) 1974-11-20
CA992547A (en) 1976-07-06
FR2199988A1 (enExample) 1974-04-19
AR205891A1 (es) 1976-06-15
AR204247A1 (es) 1975-12-10
IL43218A0 (en) 1973-11-28
ES440029A1 (es) 1977-02-16
DE2346337B2 (de) 1976-08-26
NL152246B (nl) 1977-02-15
DE2346337A1 (de) 1974-04-04

Similar Documents

Publication Publication Date Title
FR2199988B1 (enExample)
JPS539212B2 (enExample)
JPS4923550U (enExample)
JPS4957368U (enExample)
FR2236889A1 (enExample)
JPS4915985U (enExample)
JPS4936825U (enExample)
JPS49550U (enExample)
FR2176290A5 (enExample)
JPS5256478Y2 (enExample)
FR2179361A5 (enExample)
JPS4972075U (enExample)
JPS48101616U (enExample)
JPS49101016U (enExample)
CS173851B1 (enExample)
BG17922A1 (enExample)
CH566258A5 (enExample)
CH568085A5 (enExample)
BG18223A1 (enExample)
AU480295A (enExample)
CH587602A5 (enExample)
CH560847A5 (enExample)
CH1291872A4 (enExample)
CH563042A5 (enExample)
CH559647A5 (enExample)